Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.36 |
| ▸ | FABP3 | P05413 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30917295 | 0.97 | CA4 (0.53) | CA4CA1CA12CA2CA9 | |
| SCHEMBL2947828 | 0.93 | CA4 (0.50) | CA4CA1CA12CA2CA9 | |
| Lithium Ion SCHEMBL3464173 | 0.93 | CA4 (0.50) | CA4CA1CA12CA2CA9 | |
| SCHEMBL284370 | 0.93 | CA4 (0.56) | CA4CA1CA12CA2CA9 | |
| SCHEMBL866376 | 0.93 | CA4 (0.50) | CA4CA1CA12CA2CA9 | |
| SCHEMBL5183804 | 0.93 | CA4 (0.50) | CA4CA1CA12CA2CA9 | |
| SCHEMBL10627868 | 0.93 | CA4 (0.50) | CA4CA1CA12CA2CA9 | |
| SCHEMBL1882178 | 0.93 | CA4 (0.50) | CA4CA1CA12CA2CA9 | |
| Zinc Ion SCHEMBL9393640 | 0.93 | CA4 (0.50) | CA4CA1CA12CA2CA9 | |
| Silver SCHEMBL17818673 | 0.93 | CA4 (0.50) | CA4CA1CA12CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040001-A | Fe-Ni bimetallic carbon-based nano-enzyme and electrode capable of cooperating with electricity generation and wastewater treatment, and preparation method and application thereof | 南京工业大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-110785430-A | RAGE proteins for the treatment of fibrosis and DNA damage mediated diseases | 海德堡大学 | 2020-02-11 | — | — | CN | disclosed |
| EP-2382235-B1 | NOVEL CAVIIDAE ALLERGEN AND USES THEREOF | HILGER CHRISTIANE (LU) | 2016-02-24 | — | — | EP | disclosed |
| US-20130198897-A1 | MODIFYING ENZYME ACTIVITY IN PLANTS | PHILIP MORRIS PRODUCTS S.A. (CH) | 2013-08-01 | — | — | US | disclosed |
| US-20130116304-A1 | TMEM195 ENCODES FOR TETRAHYDROBIOPTERIN-DEPENDENT ALKYLGLYCEROL MONOOXYGENASE ACTIVITY | Werner, Ernst R. (AT) | 2013-05-09 | — | — | US | disclosed |
| EP-2561068-A1 | TMEM195 ENCODES FOR TETRAHYDROBIOPTERIN-DEPENDENT ALKYLGLYCEROL MONOOXYGENASE ACTIVITY | Medizinische Universität Innsbruck (AT) | 2013-02-27 | — | — | EP | disclosed |
| EP-2550358-A1 | MODIFYING ENZYME ACTIVITY IN PLANTS | Philip Morris Products S.A. (CH) | 2013-01-30 | — | — | EP | disclosed |
| US-20120196325-A1 | LACTOBACILLUS ACIDOPHILUS NUCLEIC ACID SEQUENCES ENCODING CARBOHYDRATE UTILIZATION-RELATED PROTEINS AND USES THEREFOR | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-08-02 | — | — | US | disclosed |
| US-20120149590-A1 | LACTOBACILLUS ACIDOPHILUS NUCLEIC ACID SEQUENCES ENCODING CELL SURFACE PROTEIN HOMOLOGUES AND USES THEREFORE | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-06-14 | — | — | US | disclosed |
| US-8178337-B2 | Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor | NORTH CAROLINA STATE UNIVERSITY (US) | 2012-05-15 | — | — | US | disclosed |
| WO-2005081959-A2 | LACTOBACILLUS ACIDOPHILUS NUCLEIC ACID SEQUENCES ENCODING PROTEASE HOMOLOGUES AND USES THEREFOR | NORTH CAROLINA STATE UNIVERSITY (US) | 2005-09-09 | — | — | WO | disclosed |
| US-20050123941-A1 | Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof | NORTH CAROLINA STATE UNIVERSITY | 2005-06-09 | — | — | US | disclosed |
| US-20050112612-A1 | Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore | NORTH CAROLINA STATE UNIVERSITY | 2005-05-26 | — | — | US | disclosed |
| US-6869784-B2 | Passivation of nerve agents by surface modified enzymes stabilized by non-covalent immobilization on robust, stable particles | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AMERICA (US) | 2005-03-22 | — | — | US | disclosed |
| WO-2005001057-A2 | LACTOBACILLUS ACIDOPHILUS NUCLEIC ACIDS ENCODING FRUCTO-OLIGOSACCHARIDE UTILIZATION COMPOUNDS AND USES THEREOF | NORTH CAROLINA STATE UNIVERSITY (US) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004096992-A2 | LACTOBACILLUS ACIDOPHILUS NUCLEIC ACID SEQUENCES ENCODING CELL SURFACE PROTEIN HOMOLOGUES AND USES THEREFORE | NORTH CAROLINA STATE UNIVERSITY (US) | 2004-11-11 | — | — | WO | disclosed |
| US-20040029243-A1 | Passivation of nerve agents by surface modified enzymes stabilized by non-covalent immobilization on robust, stable particles | NAVY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE | 2004-02-12 | — | — | US | disclosed |
| US-20030211586-A1 | Passivation of nerve agents by surface modified enzymes stabilized by non-covalent immobilization on robust, stable particles | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2003-11-13 | — | — | US | disclosed |
| US-20020151030-A1 | Claspin proteins and methods of use thereof | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2002-10-17 | — | — | US | disclosed |
| WO-2002033115-A2 | CLASPIN PROTEINS AND METHODS OF USE THEREOF | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050123941-A1 | Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof | FOS, FOSB, FBP1 | CA4 176/4885CA1 158/4885CA12 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.